维克萨斯:对当前理解和新兴治疗策略的审查
Robert Holden1, Yogeshraj Jeelal2,3, Andrew McLean-Tooke4
1Clinical Immunology, Royal Perth Hospital, Perth, WA, Australia.
Frontiers in immunology
|August 12, 2025
概括
由UBA1基因突变引起的VEXAS综合征,将克隆性血液形成与免疫失调联系在一起. 目前的治疗方法提供了部分缓解,但干细胞移植是治愈性的,新疗法正在出现.
科学领域:
- 遗传学和免疫学 遗传学和免疫学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 维克萨斯综合征是一种晚发自发炎性疾病,由体质UBA1基因突变引起.
- 突变导致缺陷的无处不在,ER压力和先天免疫路径激活.
- 它表现为炎症症状和克隆性血液形成,桥梁性自身炎症和血液性瘤.
研究的目的:
- 审查VEXAS综合征遗传学,细胞机制和临床方面的最新进展.
- 评估当前和新兴的治疗策略.
- 为未来的研究和临床试验提出路线图.
主要方法:
- 文献综述合成遗传,细胞和临床数据.
- 对治疗方法的分析,包括免疫抑制和向治疗.
- 评估作为治愈选择的异性造血干细胞移植.
主要成果:
- 维克萨斯综合征的特征是UBA1突变,导致蛋白质降解和免疫激活受损.
- 具有UBA1突变的克隆性造血会影响造血干细胞和祖细胞.
- 像免疫抑制剂这样的当前疗法提供了有限的疗效,而向和移植策略显示出希望.
结论:
- 维克萨斯综合征可以被看作是一种与年龄相关的蛋白质体病变.
- 它将克隆性血液形成与先天性免疫失调统一.
- 协调的响应标准和进一步的研究对于有效的管理至关重要.
相关概念视频
Varicose Veins II: Diagnostic Studies and Interprofessional Care
31
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
31
Esophageal Varices-II: Clinical Features and Management
139
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
139
Treatment Strategies for Psychological Disorders
270
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
270
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
225
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
225
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


